IVC Filter Lawsuit Trial Starts This Week
The first case against medical device maker C.R. Bard goes to trial this week in Phoenix, AZ.
Over 3,000 lawsuits are pending against Bard in the United States. Plaintiffs allege that Bard’s IVC filter is unsafe and has been linked to serious complications and death. The bellwether trial, Sherr-Una Booker v C.R. Bard Inc. and Bard Vascular Inc, is scheduled to begin on March 13, 2018. Booker has alleged that her complications include filter tilting, fracture and perforation according to DrugWatch.com. We will be watching closely to see how this trial unfolds and what the implications may be for other victims seeking legal recourse.
In a 2015 article, NBC news revealed that Bard continued to sell “G2” IVC filters for five years after it knew that the devices had potentially fatal flaws. It goes on to state that a Bard document “that includes data through 2010 showed the G2 series filters had more fractures, migrations and reported problems than any of its competitors.”
The G2 series was a replacement device for the Bard’s Recovery IVC, reported by NBC to have been linked to 27 deaths and 300 non-fatal complications. In an interesting twist, Kay Fuller, a regulatory affairs expert and former Bard employee, claims that the signature on the FDA application for the Recovery was, in fact, not her signature but rather, a forgery.
What is an IVC filter?
An inferior vena cava filter (IVC) is a metal vascular device designed to protect against blood clots in the vena cava, the body’s largest vein. An IVC filter is often implanted in individuals who are prone to blood clots, are at risk for pulmonary embolism, and/or cannot take anticoagulants (blood thinners). The device is placed into the inferior vena cava, located in the abdomen, in order to prevent blood clots from traveling from the lower half of the body to the heart and lungs. Factors that raise the risk of blood clots include: obesity, physical trauma, diabetes, and immobility, among others.
Most IVC filters are intended for short-term use, and are meant to be removed within a few months. However, many people with IVC filters in place have found that the filter cannot be safely taken out, and so face an increased risk that the filter might cause harm.
If in fact Bard is found to have placed patients at risk for injury or death with their device, those individuals who have suffered the consequences deserve justice. If you or someone in your family has had one of these blood clot filters put in place, contact a personal injury lawyer at Munley Law for more information.
Share this post: